Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ars Pharmaceuticals Inc (SPRY)

Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 791,632
  • Shares Outstanding, K 96,895
  • Annual Sales, $ 30 K
  • Annual Income, $ -54,370 K
  • 60-Month Beta 0.88
  • Price/Sales 24,966.61
  • Price/Cash Flow N/A
  • Price/Book 3.50
Trade SPRY with:

Options Overview Details

View History
  • Implied Volatility 78.54% ( -8.52%)
  • Historical Volatility 37.36%
  • IV Percentile 24%
  • IV Rank 32.05%
  • IV High 200.62% on 09/19/23
  • IV Low 20.97% on 06/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 376
  • Volume Avg (30-Day) 100
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 10,602
  • Open Int (30-Day) 10,020

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.16
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +27.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.58 +7.78%
on 06/20/24
9.37 -12.81%
on 06/12/24
-0.66 (-7.47%)
since 05/21/24
3-Month
7.58 +7.78%
on 06/20/24
11.27 -27.51%
on 03/28/24
-0.83 (-9.22%)
since 03/21/24
52-Week
2.55 +220.39%
on 09/20/23
11.27 -27.51%
on 03/28/24
+1.82 (+28.66%)
since 06/21/23

Most Recent Stories

More News
Why Shares of ARS Pharmaceuticals Are Plummeting on Wednesday

The company received a Complete Response Letter from the FDA regarding its lead therapy.

SPRY : 8.17 (+5.69%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 8.17 (+5.69%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 8.17 (+5.69%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 8.17 (+5.69%)

Business Summary

ARS Pharmaceuticals Inc. is dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions which could lead to anaphylaxis. The company is developing neffy(TM) an intranasal epinephrine product in clinical development for patients and their caregivers...

See More

Key Turning Points

3rd Resistance Point 8.86
2nd Resistance Point 8.53
1st Resistance Point 8.35
Last Price 8.17
1st Support Level 7.84
2nd Support Level 7.51
3rd Support Level 7.33

See More

52-Week High 11.27
Last Price 8.17
Fibonacci 61.8% 7.94
Fibonacci 50% 6.91
Fibonacci 38.2% 5.88
52-Week Low 2.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar